StonvexLoading…
StonvexStonvexStonvexCore line items from VST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.00B | $17.59B | $12.78B | $8.00B |
Operating Income | $1.50B | $1.91B | $1.43B | $395.00M |
Net Income | $1.03B | $944.00M | $711.00M | $59.00M |
EPS (Diluted) | $2.87 | $2.18 | $1.64 | $-0.11 |
Total Assets | $41.31B | $41.55B | $38.02B | $38.15B |
Total Liabilities | $35.70B | $36.44B | $32.80B | $33.31B |
Cash & Equivalents | $634.00M | $785.00M | $602.00M | $458.00M |
Free Cash Flow OCF − CapEx | $316.00M | $1.32B | $722.00M | $-287.00M |
Shares Outstanding | 338.08M | 338.06M | 338.68M | 339.12M |